nitazoxanide and its Impurities

Nitazoxanide is a broad-spectrum anti-infective drug that markedly modulates the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, in addition to viruses. It belongs to the class of drugs known as thiazolides.Reference standards of Nitazoxanide API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 19 results for nitazoxanide Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 14 61000

Nitazoxanide

Nitazoxanide


  • Catalogue No.:PA 14 61000

  • CAS :

    55981-09-4

  • Molecular Formula : C12H9N3O5S

  • Molecular Weight : 307.28

Drug Reference Standards & Impurity Synthesis in India
PA 14 61510

Tizoxanide

Tizoxanide


  • Catalogue No.:PA 14 61510

  • CAS :

    173903-47-4

  • Molecular Formula : C10H7N3O4S

  • Molecular Weight : 265.25

Drug Reference Standards & Impurity Synthesis in India
PA 14 61520

5-Nitrothiazole-2-amine

5-Nitrothiazole-2-amine


  • Catalogue No.:PA 14 61520

  • CAS :

    121-66-4

  • Molecular Formula : C3H3N3O2S

  • Molecular Weight : 145.14

Drug Reference Standards & Impurity Synthesis in India
PA 14 61530

2-Acetoxy-N-(2-thiazolyl)benzamide

2-Acetoxy-N-(2-thiazolyl)benzamide


  • Catalogue No.:PA 14 61530

  • CAS :

    402848-76-4

  • Molecular Formula : C12H10N2O3S

  • Molecular Weight : 262.28

Drug Reference Standards & Impurity Synthesis in India
PA 14 61540

2-[[(5-Nitro-2-thiazolyl)amino]carbonyl]phenyl 2-(acetyloxy)benzoate

2-[[(5-Nitro-2-thiazolyl)amino]carbonyl]phenyl 2-(acetyloxy)benzoate


  • Catalogue No.:PA 14 61540

  • CAS :

    952686-58-7

  • Molecular Formula : C19H13N3O7S

  • Molecular Weight : 427.39

Drug Reference Standards & Impurity Synthesis in India
PA STI 061030

Methyl 1-(2-Carboxyphenyl)-2,3,4-tri-O-acetyl-α-D-glucopyranuronate-d4

Methyl 1-(2-Carboxyphenyl)-2,3,4-tri-O-acetyl-α-D-glucopyranuronate-d4


  • Catalogue No.:PA STI 061030

  • CAS :

    NA

  • Molecular Formula : C20H18D4O12

  • Molecular Weight : 458.41

Drug Reference Standards & Impurity Synthesis in India
PA STI 063390

Methyl 1-[[2-N-(5-Nitrothiazolyl)carboxamido]phenyl]-2,3,4- tri-O-acetyl-β-D-glucopyranuronate-d4

Methyl 1-[[2-N-(5-Nitrothiazolyl)carboxamido]phenyl]-2,3,4- tri-O-acetyl-β-D-glucopyranuronate-d4


  • Catalogue No.:PA STI 063390

  • CAS :

    NA

  • Molecular Formula : C23H19D4N3O13S

  • Molecular Weight : 585.53

Drug Reference Standards & Impurity Synthesis in India
PA STI 060620

Methyl 1-((2-Benzyloxycarbonxyl)phenyl)-2,3,4-tri-O-acetyl-β-D- glucopyranuronate-d4

Methyl 1-((2-Benzyloxycarbonxyl)phenyl)-2,3,4-tri-O-acetyl-β-D- glucopyranuronate-d4


  • Catalogue No.:PA STI 060620

  • CAS :

    NA

  • Molecular Formula : C27H24D4O12

  • Molecular Weight : 548.53

Drug Reference Standards & Impurity Synthesis in India
PA STI 060830

Methyl 1-(2-Carboxyphenyl)-2,3,4-tri-O-acetyl-β-D-glucopyranuronate-d4

Methyl 1-(2-Carboxyphenyl)-2,3,4-tri-O-acetyl-β-D-glucopyranuronate-d4


  • Catalogue No.:PA STI 060830

  • CAS :

    NA

  • Molecular Formula : C20H18D4O12

  • Molecular Weight : 458.41

Drug Reference Standards & Impurity Synthesis in India
PA STI 067820

Nitazoxanide-d4

Nitazoxanide-d4


  • Catalogue No.:PA STI 067820

  • CAS :

    1246819-17-9

  • Molecular Formula : C12H5D4N3O5S

  • Molecular Weight : 311.31

Drug Reference Standards & Impurity Synthesis in India
PA STI 083400

Tizoxanide-d4

Tizoxanide-d4


  • Catalogue No.:PA STI 083400

  • CAS :

    1246817-56-0

  • Molecular Formula : C10H3D4N3O4S

  • Molecular Weight : 269.27

Drug Reference Standards & Impurity Synthesis in India
PA USP1463960

Nitazoxanide (1463960)

Nitazoxanide (1463960)


  • Catalogue No.:PA USP1463960

  • CAS :

    55981-09-4

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA USP1463971

Nitazoxanide Related Compound A (2-Amino-5-nitrothiazole) (1463971)

Nitazoxanide Related Compound A (2-Amino-5-nitrothiazole) (1463971)


  • Catalogue No.:PA USP1463971

  • CAS :

    121-66-4

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 14 61550

Tizoxanide Sulfate

Tizoxanide Sulfate


  • Catalogue No.:PA 14 61550

  • CAS :

    1391053-06-7

  • Molecular Formula : C10H7N3O7S2

  • Molecular Weight : 345.3

Drug Reference Standards & Impurity Synthesis in India
PA 14 61560

Tizoxanide Glucuronide Sodium Salt

Tizoxanide Glucuronide Sodium Salt


  • Catalogue No.:PA 14 61560

  • CAS :

    221287-83-8

  • Molecular Formula : C16H14N3NaO10S

  • Molecular Weight : 463.35

Drug Reference Standards & Impurity Synthesis in India
PA 14 61570

Methyl 1-[[2-N-(5-Nitrothiazolyl)carboxamido]phenyl]-2,3,4- tri-O-acetyl-β-D-glucopyranuronate

Methyl 1-[[2-N-(5-Nitrothiazolyl)carboxamido]phenyl]-2,3,4- tri-O-acetyl-β-D-glucopyranuronate


  • Catalogue No.:PA 14 61570

  • CAS :

    221287-92-9

  • Molecular Formula : C23H23N3O13S

  • Molecular Weight : 581.51

Drug Reference Standards & Impurity Synthesis in India
PA 14 0611000

Methyl 1-(2-Carboxyphenyl)-2,3,4-tri-O-acetyl-β-D-glucopyranuronate

Methyl 1-(2-Carboxyphenyl)-2,3,4-tri-O-acetyl-β-D-glucopyranuronate


  • Catalogue No.:PA 14 0611000

  • CAS :

    221287-90-7

  • Molecular Formula : C20H22O12

  • Molecular Weight : 454.38

Drug Reference Standards & Impurity Synthesis in India
PA 14 0611001

Methyl 1-((2-Benzyloxycarbonxyl)phenyl)-2,3,4-tri-O-acetyl-β-D-glucopyranuronate

Methyl 1-((2-Benzyloxycarbonxyl)phenyl)-2,3,4-tri-O-acetyl-β-D-glucopyranuronate


  • Catalogue No.:PA 14 0611001

  • CAS :

    221287-88-3

  • Molecular Formula : C27H28O12

  • Molecular Weight : 544.51

Drug Reference Standards & Impurity Synthesis in India
PA 14 0611002

2-(Nitroso(5-nitrothiazol-2-yl)carbamoyl)phenyl acetate

2-(Nitroso(5-nitrothiazol-2-yl)carbamoyl)phenyl acetate


  • Catalogue No.:PA 14 0611002

  • CAS :

    NA

  • Molecular Formula : C12H8N4O6S

  • Molecular Weight : 336.28

pharmaffiliates